ASTA Comments to FDA on Allergen Thresholds
ASTA issued comments to the Food and Drug Administration (FDA) in May 2013 regarding allergen thresholds, advocating for FDA's role to protect public health and the food supply by adopting allergen policies based on sound science and thoughtful policy.
05/01/2013 at 5:15 am
2
Related Resources
ASTA Comments on Poppy Seed Practices and Safety
On June 16, 2025, ASTA submitted comments in response to the U.S. Food and Drug Administration's (FDA) Request for Information (RFI) on industry practices on the growing, harvesting, processing, and distribution of poppy seeds. The comments outline the typical poppy seed supply chains, as well as the role of pre- and post-harvest processing steps (e.g., microbiological treatment, baking, etc.) in reducing opiate alkaloid levels in poppy seed-based products.
Multi-Industry Letter to FDA on Possible Use of 3rd Party Audit Data
ASTA signed onto a letter from multiple industries to FDA's Associate Commissioner Michael Rogers in September 2024 requesting a meeting to discuss the potential use of 3rd party food safety audit data as part of the Agency's inspection strategy.
